ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 037,18
-1,34%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. IO Biotech Inc (IOBT)

  7. IO Biotech Inc (IOBT) Actualités

IOBT IO Biotech Inc

1,48
-0,05 (-3,27%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IO Biotech Inc IOBT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -3,27% 1,48 23:30:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,53 1,48 1,58 1,48 1,53
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15/4/202414:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
09/4/202418:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05/4/202414:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
11/3/202421:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202422:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
05/3/202423:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:46EDGAR2Form 8-K - Current report
05/3/202422:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
26/2/202422:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
08/1/202414:11EDGAR2Form 8-K - Current report
21/12/202314:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
24/11/202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:12GLOBEIO Biotech Announces 2023 Third Quarter Results
13/11/202314:10EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
10/11/202314:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
08/11/202322:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
01/11/202313:30GLOBEIO Biotech Presents Three Posters at the Society for..
23/10/202307:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
03/10/202322:30GLOBEIO Biotech Announces Three Poster Presentations at the..
12/9/202322:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/9/202314:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
11/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
07/9/202316:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202314:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
30/8/202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
16/8/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202323:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/8/202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202314:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202314:31EDGAR2Form 8-K - Current report
11/8/202314:30GLOBEIO Biotech Announces 2023 Second Quarter Results
11/8/202314:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
10/8/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202314:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
07/8/202314:31EDGAR2Form 8-K - Current report
07/8/202314:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
28/7/202314:05GLOBEIO Biotech Announces First Patient Dosed in..
25/7/202322:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
19/7/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202322:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/7/202322:05EDGAR2Form 8-K - Current report
18/7/202322:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
14/6/202314:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
01/6/202314:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

Dernières Valeurs Consultées

NASDAQ
IOBT
IO Biotech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés